BEYFORTUS

Nirsevimab · Sanofi Vaccines US Inc.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for BEYFORTUS, covering 2023-07-17 to 2026-04-24. Get the full timeline:

Most recent: EMA Authorised: Beyfortus (nirsevimab) — Sanofi Winthrop Industrie